Wuxi Discovery Services

Enabling Unbounded Possibilities The WuXi AppTec Discovery Services supports its clients in the discovery and development of future therapeutics. Through comprehensive discovery and technology platforms, peer-recognized scientific leadership and expertise in oncology, immunology, infectious disease, neurosciences, fibrosis, cardiovascular and metabolic disease, WuXi AppTec Discovery Services works collaboratively to rapidly advance programs from target through to preclinical selection and beyond. Our services encompass biology, chemistry, structural biology and biophysics, in addition to the capabilities of recently acquired HD Biosciences (HDB), and is trusted by over 3,000 international clients, ranging from pharma and biotech to academia and non-profit institutions. This integration of capabilities allows a collaborative environment with closer points of contact for our partners and discovery teams, enabling us to enhance efficiency and productivity. WuXi AppTec strives to continually develop and enhance its scientific capabilities and technology to maintain its industry leading position. We aim to provide outstanding services to our existing partners and to the broader discovery community!